B

Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315

Watchlist Manager
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
Watchlist
Price: 5.6 HKD -2.78%
Market Cap: 2.2B HKD
Have any thoughts about
Biocytogen Pharmaceuticals Beijing Co Ltd?
Write Note

Biocytogen Pharmaceuticals Beijing Co Ltd
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biocytogen Pharmaceuticals Beijing Co Ltd
Deferred Income Tax Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Deferred Income Tax Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
B
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
Deferred Income Tax
ÂĄ1.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Deferred Income Tax
ÂĄ56.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Deferred Income Tax
ÂĄ15.4m
CAGR 3-Years
28%
CAGR 5-Years
2%
CAGR 10-Years
6%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Deferred Income Tax
ÂĄ53.7m
CAGR 3-Years
22%
CAGR 5-Years
33%
CAGR 10-Years
30%
Imeik Technology Development Co Ltd
SZSE:300896
Deferred Income Tax
ÂĄ28.8m
CAGR 3-Years
126%
CAGR 5-Years
72%
CAGR 10-Years
N/A

See Also

What is Biocytogen Pharmaceuticals Beijing Co Ltd's Deferred Income Tax?
Deferred Income Tax
1.9m CNY

Based on the financial report for Dec 31, 2023, Biocytogen Pharmaceuticals Beijing Co Ltd's Deferred Income Tax amounts to 1.9m CNY.

Back to Top